ARTICLES BY THIS AUTHOR
- 5/23/2021
FDA clears Glenmark’s generic Firazyr
Firazyr injection had a market value of roughly $223.4 million for the 12 months ended March 2021, according to IQVIA. - 5/23/2021
AAM makes 2 key appointments
Erik Komendant will assume the role of the Association for Accessible Medicines’ senior vice president of government affairs and Steven Selde will serve as director of the Biosimilars Council. - 5/20/2021
Kinney Drugs kicks off contest as it expands vaccinations
With Kinney Drugs now vaccinating people 12 years old and older, the chain is kicking off a contest to help customers achieve their post-COVID dreams. - 5/20/2021
Fresenius Kabi rolls out generic Torisel
Fresenius Kabi's generic Torisel is indicated to treat renal cell carcinoma. - 5/20/2021
CVS Pharmacy attains 100% Beauty Mark compliance, enters new phase of effort
The next phase of CVS Pharmacy’s Beauty Mark initiative illuminates new consumer data showing the relationship between screen time and mental health. - 5/19/2021
NCPA urges CMS clear, consistent quality measurements for community pharmacies
The National Community Pharmacists Association said that inconsistent application of the definition of quality led to billions in pharmacy DIR fees and that it must be resolved by the Centers for Medicare and Medicaid Services. - 5/19/2021
NACDS Total Store Expo to be held virtually
Due to continued uncertainties amid the pandemic, the National Association of Chain Drug Stores will host the 2021 NACDS Total Store Expo virtually from Aug. 23 to 25. - 5/19/2021
Webinar explores how CVS is helping patients navigate mental health services
The webinar featured Aetna Behavioral Health’s Ashley Karpinski, who discussed how CVS Health is responding to the growing need for mental health services amid the pandemic. - 5/19/2021
Supreme Court denies Sandoz petition to review biosimilar Enbrel case
The Supreme Court’s decision not to review the case means that Sandoz's Enbrel biosimilar, Erelzi, will not be available until 2029. - 5/19/2021
CVS Health debuts clinical trial services business
CVS Health said that the new business will continue to deliver research solutions for COVID-19 and beyond with community presence, data capabilities and healthcare expertise.